Evidence map›Paper›PMID 35714644›Full record

ArticleThe Lancet. Global health2022

Statin use in low-income and middle-income countries - Authors' reply.

David Flood, Maja E Marcus, Silver K Bahendeka, Sahar Saeedi Moghaddam, Corine Houehanou, Sebastian Vollmer, Mark D Huffman

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The Lancet. Global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

David FloodDivision of Hospital Medicine, Department of Medicine, University of Michigan, Ann Arbor, MI 48109, USA; Center for Indigenous Health Research, Wuqu' Kawoq, Tecpán, Guatemala; Research Center for the Prevention of Chronic Diseases, Institute of Nutrition of Central America and Panama, Guatemala City, Guatemala. Electronic address: dcflood@umich.edu.
Maja E MarcusDepartment of Economics and Centre for Modern Indian Studies, University of Göttingen, Göttingen, Germany.
Silver K BahendekaSt Francis Hospital Nsambya, Uganda Martyrs University, Kampala, Uganda.
Sahar Saeedi MoghaddamEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Corine HouehanouLaboratory of Epidemiology of Chronic and Neurological Diseases, Faculty of Health Sciences, University of Abomey-Calavi, Cotonou, Benin.
Sebastian VollmerDepartment of Economics and Centre for Modern Indian Studies, University of Göttingen, Göttingen, Germany.
Mark D HuffmanDepartment of Medicine and Global Health Center, Washington University in St Louis, St Louis, MO, USA; Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.

Funding

Research BaseP30DK092926 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARY ELLEN MICHELE HEISLER, ADESUWA B OLOMU · 2011 to 2026
$10.0M
NIDDK NIH HHS P30 DK092926
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Developing CountriesHydroxymethylglutaryl-CoA Reductase InhibitorsHumansIncomePovertyHydroxymethylglutaryl-CoA Reductase Inhibitors

Identifiers

PMID35714644
PMCPMC10069291

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.